• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Autocrine mitogen IgEGF cooperates with c-myc or with the Hcs locus during hepatocarcinogenesis in transgenic mice.

作者信息

Tönjes R R, Löhler J, O'Sullivan J F, Kay G F, Schmidt G H, Dalemans W, Pavirani A, Paul D

机构信息

Department of Cell Biology, Fraunhofer Institut für Toxikologie und Molekularbiologie, Hannover, Germany.

出版信息

Oncogene. 1995 Feb 16;10(4):765-8.

PMID:7862454
Abstract

Hepatocarcinogenesis is deterministic in transgenic mice expressing in the liver gene construct Alb-DS4 that encodes autocrine growth factor IgEGF (D Stern et al. (1987), Science 235: 321-324), causing their death within 7.1 months. Hepatic expression of construct AAT-myc encoding murine c-myc causes liver cancer in 44% of the mice at 14.8 months. Cooperation of these genes was evident in CD2F1 transgenics bearing Alb-DS4 plus AAT-myc, in which accelerated hepatocellular carcinoma (HCC) formation caused death of all mice within 4.4 months. Alb-DS4 also cooperates with the Hcs locus, which in C3H/HeJ mice mediates high susceptibility to spontaneous hepatocarcinogenesis, causing accelerated formation of HCC to which mice succumbed at 5.1 months. Thus, genes that predispose to HCC formation cooperate in transgenic mice and their interaction is a key to understand mechanisms that cause liver cancer.

摘要

相似文献

1
Autocrine mitogen IgEGF cooperates with c-myc or with the Hcs locus during hepatocarcinogenesis in transgenic mice.
Oncogene. 1995 Feb 16;10(4):765-8.
2
Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer.肝癌转基因小鼠模型中肝癌发生的分子机制。
Toxicol Pathol. 2005;33(1):181-4. doi: 10.1080/01926230590522095.
3
Development of pulmonary bronchiolo-alveolar adenocarcinomas in transgenic mice overexpressing murine c-myc and epidermal growth factor in alveolar type II pneumocytes.在II型肺泡上皮细胞中过表达鼠源c-myc和表皮生长因子的转基因小鼠中肺细支气管肺泡腺癌的发生
Br J Cancer. 2001 Mar 23;84(6):813-8. doi: 10.1054/bjoc.2000.1676.
4
Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.共表达c-myc和转化生长因子-α的转基因小鼠肝脏中肿瘤发生的演变
Am J Pathol. 1996 Aug;149(2):407-28.
5
Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.E2F-1在肝癌发生转基因小鼠模型中的双重功能。
Oncogene. 2000 Oct 19;19(44):5054-62. doi: 10.1038/sj.onc.1203885.
6
Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.视网膜母细胞瘤蛋白(pRb)/E2F信号通路的破坏以及细胞凋亡的抑制是在持续表达c-myc和转化生长因子α的肝脏中发生的主要致癌事件。
Cancer Res. 1998 Jan 1;58(1):123-34.
7
Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.白蛋白-SV40 T抗原转基因大鼠自发肝癌发生过程中特定基因表达和局灶性肿瘤生长的改变。
Mol Carcinog. 2004 Jul;40(3):150-9. doi: 10.1002/mc.20029.
8
The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice.乙肝病毒X基因增强c-myc诱导的转基因小鼠肝脏肿瘤发生。
Oncogene. 1997 Jan 30;14(4):395-404. doi: 10.1038/sj.onc.1200850.
9
Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II.土拨鼠肝炎病毒/c-myc小鼠中的肝癌发生:持续的细胞增殖和胰岛素样生长因子II的双相激活
Hepatology. 1997 Apr;25(4):874-83. doi: 10.1002/hep.510250415.
10
Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine.在经二乙基亚硝胺处理的转基因小鼠中,肝细胞生长因子通过c-Met自分泌激活和增强血管生成来促进肝癌发生。
Oncogene. 2002 Mar 14;21(12):1791-9. doi: 10.1038/sj.onc.1205248.

引用本文的文献

1
Epidermal Growth Factor Receptor Inhibition With Erlotinib in Liver: Dose De-Escalation Pilot Trial as an Initial Step in a Chemoprevention Strategy.厄洛替尼对肝脏表皮生长因子受体的抑制作用:剂量递减试点试验作为化学预防策略的第一步
Gastro Hep Adv. 2024 Jan 29;3(3):426-439. doi: 10.1016/j.gastha.2024.01.009. eCollection 2024.
2
EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma.EGF rs4444903 多态性与 HCV 相关肝硬化和 HBV/HCV 相关肝细胞癌的风险相关。
Int J Clin Oncol. 2021 Nov;26(11):2053-2064. doi: 10.1007/s10147-021-01994-w. Epub 2021 Jul 21.
3
The EGFR-P38 MAPK axis up-regulates PD-L1 through miR-675-5p and down-regulates HLA-ABC via hexokinase-2 in hepatocellular carcinoma cells.
EGFR-P38 MAPK 轴通过 miR-675-5p 上调 PD-L1,并通过己糖激酶-2 下调 HLA-ABC 在肝癌细胞中。
Cancer Commun (Lond). 2021 Jan;41(1):62-78. doi: 10.1002/cac2.12117. Epub 2021 Jan 1.
4
MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma.肝细胞癌中的MAPK/ERK信号通路
Cancers (Basel). 2021 Jun 17;13(12):3026. doi: 10.3390/cancers13123026.
5
Oncogenic driver genes and tumor microenvironment determine the type of liver cancer.致癌驱动基因和肿瘤微环境决定肝癌的类型。
Cell Death Dis. 2020 May 4;11(5):313. doi: 10.1038/s41419-020-2509-x.
6
Genetically Engineered Mouse Models for Liver Cancer.用于肝癌研究的基因工程小鼠模型。
Cancers (Basel). 2019 Dec 19;12(1):14. doi: 10.3390/cancers12010014.
7
The Kinome of Human Alveolar Type II and Basal Cells, and Its Reprogramming in Lung Cancer.人肺泡 II 型和基底细胞的激酶组及其在肺癌中的重编程。
Am J Respir Cell Mol Biol. 2019 Oct;61(4):481-491. doi: 10.1165/rcmb.2018-0283OC.
8
Oxidative stress mediates an increased formation of vascular endothelial growth factor in human hepatocarcinoma cells exposed to erlotinib.氧化应激介导暴露于厄洛替尼的人肝癌细胞中血管内皮生长因子生成增加。
Oncotarget. 2017 Jul 6;8(34):57109-57120. doi: 10.18632/oncotarget.19055. eCollection 2017 Aug 22.
9
c-MYC-Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease.c-MYC 致使肝脏病变:c-MYC 在肝细胞功能、稳态及疾病中的作用
Genes (Basel). 2017 Apr 19;8(4):123. doi: 10.3390/genes8040123.
10
Alpha-fetoprotein-targeted reporter gene expression imaging in hepatocellular carcinoma.肝细胞癌中α-甲胎蛋白靶向报告基因表达成像
World J Gastroenterol. 2016 Jul 21;22(27):6127-34. doi: 10.3748/wjg.v22.i27.6127.